x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

health & fitness medicine

All Episodes

0:00

Improving Patient Care and Lowering Costs in...

Empowered Patient Podcast ·

2025/09/19

Kevin Freeman, Chief Commercial Officer at Health Catalyst, highlights the challenges mid-market healthcare systems are currently facing, including the predicted impact of Medicaid cuts and the increase in uninsured patients. There is a need to break down data silos and use AI and data analytics to improve the quality of care, reduce costs, and address clinician burnout. The Health Catalyst platform is designed to integrate existing technology, improve efficiency, and provide expertise and support

en

19:21

Improving Patient Care and Lowering Costs in...

Empowered Patient Podcast ·

2025/09/19

Kevin Freeman, Chief Commercial Officer at Health Catalyst, highlights the challenges mid-market healthcare systems are currently facing, including the predicted impact of Medicaid cuts and the increase in uninsured patients. There is a need to break down data silos and use AI and data analytics to improve the quality of care, reduce costs, and address clinician burnout. The Health Catalyst platform is designed to integrate existing technology, improve efficiency, and provide expertise and support

en

0:00

AI-Powered Management of Healthcare Revenue Cycles...

Empowered Patient Podcast ·

2025/09/18

Nick Nunez, a strategy and solutions engineer at RevSpring, discusses the significant staffing shortages and technology vendor fragmentation that hamper the healthcare revenue cycle teams. RevSpring is addressing these issues by providing integrated analytics that function seamlessly with existing workflows and various dashboards, helping to prioritize work and eliminate inefficiencies. AI tools are being designed to support the financial and administrative aspects of healthcare, automating certain

en

18:34

AI-Powered Management of Healthcare Revenue Cycles...

Empowered Patient Podcast ·

2025/09/18

Nick Nunez, a strategy and solutions engineer at RevSpring, discusses the significant staffing shortages and technology vendor fragmentation that hamper the healthcare revenue cycle teams. RevSpring is addressing these issues by providing integrated analytics that function seamlessly with existing workflows and various dashboards, helping to prioritize work and eliminate inefficiencies. AI tools are being designed to support the financial and administrative aspects of healthcare, automating certain

en

0:00

Using AI to Connect Patients with the Right...

Empowered Patient Podcast ·

2025/09/17

Michael Palladino, VP of Sales and Clinical Solutions at OptimizeRx, is utilizing AI to educate patients and providers, promoting shared decision-making about which medications are most likely to yield the best health outcomes. The goal is to combat information overload by precisely targeting education to specific patients and delivering that information on the patient's preferred media delivery platform. Technology-driven nudges deliver timely information, reminders about upcoming appointments,

en

19:43

Using AI to Connect Patients with the Right...

Empowered Patient Podcast ·

2025/09/17

Michael Palladino, VP of Sales and Clinical Solutions at OptimizeRx, is utilizing AI to educate patients and providers, promoting shared decision-making about which medications are most likely to yield the best health outcomes. The goal is to combat information overload by precisely targeting education to specific patients and delivering that information on the patient's preferred media delivery platform. Technology-driven nudges deliver timely information, reminders about upcoming appointments,

en

0:00

Why Hospital Printers Have Become Targets for...

Empowered Patient Podcast ·

2025/09/16

Jim LaRoe, CEO of Symphion, highlights an often overlooked cybersecurity threat posed by network-connected printers in a hospital setting. Modern printers are complex devices with numerous features that create vulnerabilities and potential access points to patient and hospital data for cybercriminals, yet they are generally managed outside of the IT security environment. The first step in ensuring printer security is to determine the number of printing devices on the network, their locations, and

en

19:09

Why Hospital Printers Have Become Targets for...

Empowered Patient Podcast ·

2025/09/16

Jim LaRoe, CEO of Symphion, highlights an often overlooked cybersecurity threat posed by network-connected printers in a hospital setting. Modern printers are complex devices with numerous features that create vulnerabilities and potential access points to patient and hospital data for cybercriminals, yet they are generally managed outside of the IT security environment. The first step in ensuring printer security is to determine the number of printing devices on the network, their locations, and

en

0:00

How Laboratory Robots Are Transforming Hydrogel...

Empowered Patient Podcast ·

2025/09/15

Sinan Gölhan, Founder and CEO of GelTech, describes the characteristics and applications for hydrogels, which are bio-friendly, super-absorbent materials similar to natural tissue. In cancer treatments, hydrogels offer a way to deliver chemotherapy drugs directly to a tumor, which can significantly increase the accuracy and efficacy of the drug. GelTech has developed a robotic instrument to streamline the time-consuming testing process for new hydrogel treatments, automating repetitive actions,

en

16:40

How Laboratory Robots Are Transforming Hydrogel...

Empowered Patient Podcast ·

2025/09/15

Sinan Gölhan, Founder and CEO of GelTech, describes the characteristics and applications for hydrogels, which are bio-friendly, super-absorbent materials similar to natural tissue. In cancer treatments, hydrogels offer a way to deliver chemotherapy drugs directly to a tumor, which can significantly increase the accuracy and efficacy of the drug. GelTech has developed a robotic instrument to streamline the time-consuming testing process for new hydrogel treatments, automating repetitive actions,

en

0:00

Treating Autoimmune-Driven Dry Eye Disease with...

Empowered Patient Podcast ·

2025/09/12

Elizabeth Jeffords, CEO and President of Iolyx Therapeutics, discusses dry eye disease and its connection to autoimmune conditions. The company's novel therapeutic topical immune modulator is designed to treat the root inflammation in the eye, which systemic drugs often fail to reach due to the blood-retina barrier. Patients with dry eye disease often have multiple comorbidities and are excluded from clinical trials, making this research even more significant in finding treatments for a growing

en

18:21

Treating Autoimmune-Driven Dry Eye Disease with...

Empowered Patient Podcast ·

2025/09/12

Elizabeth Jeffords, CEO and President of Iolyx Therapeutics, discusses dry eye disease and its connection to autoimmune conditions. The company's novel therapeutic topical immune modulator is designed to treat the root inflammation in the eye, which systemic drugs often fail to reach due to the blood-retina barrier. Patients with dry eye disease often have multiple comorbidities and are excluded from clinical trials, making this research even more significant in finding treatments for a growing

en

0:00

Using AI in Drug Development to Protect Brain Enzyme...

Empowered Patient Podcast ·

2025/09/10

Gene Mack, CEO and President of Gain Therapeutics, is combining AI-powered drug discovery with the development of allosteric modulators, drugs that bind to unique sites on proteins. The company's AI platform, Magellan, is crucial for accelerating drug discovery by reducing the time for computational screening of potential drug compounds. Their lead compound is showing promising results as a potential disease-modifying therapy for Parkinson's disease, aiming to halt the progression of the disease

en

21:00

Using AI in Drug Development to Protect Brain Enzyme...

Empowered Patient Podcast ·

2025/09/10

Gene Mack, CEO and President of Gain Therapeutics, is combining AI-powered drug discovery with the development of allosteric modulators, drugs that bind to unique sites on proteins. The company's AI platform, Magellan, is crucial for accelerating drug discovery by reducing the time for computational screening of potential drug compounds. Their lead compound is showing promising results as a potential disease-modifying therapy for Parkinson's disease, aiming to halt the progression of the disease

en

0:00

Advancement in Abuse-Deterrent Opioids with Paul Howe...

Empowered Patient Podcast ·

2025/09/09

Paul Howe, COO of Protega Pharmaceuticals, is focused on how abuse-deterrent technology can address the opioid crisis and the need for mandates for insurance coverage of safer abuse-deterrent formulations. The SentryBond technology was specifically designed for immediate-release opioids to make it difficult to manipulate pills for abuse via crushing, inhaling, or injecting. Protega partnered with software company Opus to offer a program that helps educate chronic pain patients, manage their

en

19:35

Advancement in Abuse-Deterrent Opioids with Paul Howe...

Empowered Patient Podcast ·

2025/09/09

Paul Howe, COO of Protega Pharmaceuticals, is focused on how abuse-deterrent technology can address the opioid crisis and the need for mandates for insurance coverage of safer abuse-deterrent formulations. The SentryBond technology was specifically designed for immediate-release opioids to make it difficult to manipulate pills for abuse via crushing, inhaling, or injecting. Protega partnered with software company Opus to offer a program that helps educate chronic pain patients, manage their

en

0:00

Leveraging Non-Dilutive Funding for Ultra-Rare...

Empowered Patient Podcast ·

2025/09/08

Dr. George Magrath, CEO of Opus Genetics, discusses the company's experience in obtaining non-dilutive funding for its ultra-rare inherited retinal disease program. He highlights the challenges and advantages of this funding source, as well as the importance of establishing relationships with patient advocacy groups and foundations to mitigate risk and increase their attractiveness to traditional investors. The drive for non-dilutive funding for ultra-rare diseases is expected to become

en

15:33

Leveraging Non-Dilutive Funding for Ultra-Rare...

Empowered Patient Podcast ·

2025/09/08

Dr. George Magrath, CEO of Opus Genetics, discusses the company's experience in obtaining non-dilutive funding for its ultra-rare inherited retinal disease program. He highlights the challenges and advantages of this funding source, as well as the importance of establishing relationships with patient advocacy groups and foundations to mitigate risk and increase their attractiveness to traditional investors. The drive for non-dilutive funding for ultra-rare diseases is expected to become

en

0:00

AI Revolutionizing Drug Development Regulatory...

Empowered Patient Podcast ·

2025/09/05

Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies. The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio's tools are designed to automate and streamline administrative aspects of the regulatory process and create a living digital record of the development

en

19:09

AI Revolutionizing Drug Development Regulatory...

Empowered Patient Podcast ·

2025/09/05

Lindsay Mateo is the Chief Commercial Officer at Weave. This company has developed a platform to automate and streamline the regulatory documentation process for FDA submission for pharmaceutical and biotech companies. The regulatory lifecycle for drug development currently involves data from various sources in digital and paper formats. Weave Bio's tools are designed to automate and streamline administrative aspects of the regulatory process and create a living digital record of the development

en

2,395 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown